Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Schöchl, Herbert ^a,b   Nienaber, Ulrike ^c   Hofer, Georg ^a   Voelckel, Wolfgang ^a   Jambor, Csilla ^d   Scharbert, Gisela ^e   Kozek Langenecker, Sibylle ^e   Solomon, Cristina ^f  

^a AUVA Trauma Center Salzburg   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f Salzburger Landeskliniken SALK ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BERIPLEX; BLOOD CLOTTING FACTOR 9 CONCENTRATE; COUMARIN; FIBRIN; FIBRINOGEN; FRESH FROZEN PLASMA; HAEMOCOMPLETTAN P; OCTAPLEX; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR; PROTHROMBIN;

ADD ON THERAPY; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; COMBINATION CHEMOTHERAPY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXTRINSICALLY ACTIVATED THROMBOELASTOMETRIC TEST; FEMALE; FIBRIN BASED THROMBOELASTOMETRIC TEST; HEMATOLOGICAL PROCEDURES; HEMOSTASIS; HUMAN; INJURY; INJURY SCALE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOELASTOMETRY; BLOOD; METHODOLOGY; MIDDLE AGED; THROMBOELASTOGRAPHY;

ADULT; BLOOD COAGULATION FACTORS; FEMALE; FIBRINOGEN; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; MALE; MIDDLE AGED; PROTHROMBIN; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 77950681467     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8948     Document Type: Article

References (67)

1. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130. 10.1097/01.TA.0000069184.82147.06, 12813333.
2. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304. 10.1016/j.injury.2006.10.003, 17214989.
3. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding following major trauma: a European guideline. Crit Care 2007, 11:R17. 10.1186/cc5686, 2151863, 17298665.
4. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006, 135:634-641. 10.1111/j.1365-2141.2006.06355.x, 17107347.
5. Stanworth SJ, Hyde CJ, Murphy MF. Evidence for indications of fresh frozen plasma. Transfus Clin Biol 2007, 14:551-556. 10.1016/j.tracli.2008.03.008, 18430602.
6. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813. 10.1097/TA.0b013e3181271ba3, 18090009.
7. Gunter OL, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008, 65:527-534. 10.1097/TA.0b013e3181826ddf, 18784564.
8. Hess JR, Dutton RB, Holcomb JB, Scalea TM. Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit?. Transfusion 2008, 48:1763-1765. 10.1111/j.1537-2995.2008.01743.x, 18482190.
9. Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, Cothren CC, Biffl WL, Banerjee A, Sauaia A. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?. J Trauma 2008, 65:261-270. 10.1097/TA.0b013e31817de3e1, 18695460.
10. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie. Vox Sang 2008, 95:112-119. 10.1111/j.1423-0410.2008.01074.x, 18557827.
11. Scalea TM, Bochicchio KM, Lumpkins K, Hess JR, Dutton R, Pyle A, Bochicchio GV. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 2008, 248:578-584.
12. Sperry JL, Ochoa JB, Gunn SR, Alarcon LH, Minei JP, Cuschieri J, Rosengart MR, Maier RV, Billiar TR, Peitzman AB, Moore EE. An FFP:PRBC transfusion ratio >/= 1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008, 65:986-993. 10.1097/TA.0b013e3181878028, 19001962.
13. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Niles SE, McLaughlin DF, Wade CE, Holcomb JB. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008, 64:S69-77. 10.1097/TA.0b013e318160ba2f, 18376175.
14. Teixeira PG, Inaba K, Shulman I, Salim A, Demetriades D, Brown C, Browder T, Green D, Rhee P. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009, 66:693-697. 10.1097/TA.0b013e31817e5c77, 19276739.
15. Chaiwat O, Lang JD, Vavilala MS, Wang J, MacKenzie EJ, Jurkovich GJ, Rivara FP. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology 2009, 110:351-360. 10.1097/ALN.0b013e3181948a97, 19164959.
16. Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008, 36:1114-1118. 10.1097/CCM.0b013e318168f89d, 18379235.
17. Serious Hazards Of Transfusion Annual Report 2007. , http://www.shotuk.org/Summary-2007.pdf
18. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, Chapman CE, Davison K, Gerrard R, Gray A, Knowles S, Love EM, Milkins C, McClelland DB, Norfolk DR, Soldan K, Taylor C, Revill J, Williamson LM, Cohen H. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006, 20:273-282. 10.1016/j.tmrv.2006.05.002, 17008165.
19. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, Hess JR, Dubick MA, Simon CD, Beekley AC, Wolf SE, Wade CE, Holcomb JB. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64:S79-85. 10.1097/TA.0b013e318160a57b, 18376176.
20. Danes AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008, 94:221-226. 10.1111/j.1423-0410.2007.01024.x, 18179679.
21. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008, 101:769-773. 10.1093/bja/aen270, 18818192.
22. Bruce D, Nokes TJ. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care 2008, 12:R105. 10.1186/cc6987, 2575594, 18706082.
23. Schick KS, Fertmann JM, Jauch KW, Hoffmann JN. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009, 13:R191. 10.1186/cc8186, 2811941, 19948037.
24. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008, 106:1366-1375. 10.1213/ane.0b013e318168b367, 18420846.
25. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997, 42:716-720. 10.1097/00005373-199704000-00023, 9137263.
26. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007, 5:289-295. 10.1111/j.1538-7836.2007.02319.x, 17109736.
27. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, Lakner M. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005, 16:301-310. 10.1097/01.mbc.0000169225.31173.19, 15870552.
28. Davis EG, MacKenzie EJ, Sacco WJ, Bain LW, Buckman RF, Champion HR, Lees PS. A new "TRISS-like" probability of survival model for intubated trauma patients. J Trauma 2003, 55:53-61. 10.1097/01.TA.0000075340.22097.B5, 12855881.
29. Lefering R. Development and validation of the revised injury severity classification score for severely injured patients. Eur J Trauma Emerg Surg 2009, 35:437-447.
30. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy--a porcine model. Br J Anaesth 2006, 97:460-467. 10.1093/bja/ael191, 16885172.
31. Haas T, Fries D, Velik-Salchner C, Oswald E, Innerhofer P. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008, 106:725-731. 10.1213/ane.0b013e318163fb26, 18292409.
32. Nielsen VG, Levy JH. Fibrinogen and bleeding: old molecule--new ideas. Anesth Analg 2007, 105:902-903. 10.1213/01.ane.0000286775.33975.6e, 17898364.
33. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009, 102:785-792. 10.1093/bja/aep089, 2683341, 19411671.
34. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995, 81:360-365. 10.1097/00000539-199508000-00026, 7542432.
35. Lampl L, Seifried E, Tisch M, Helm M, Maier B, Bock KH. [Hemostatic disorders following polytrauma--the role of physiologic coagulation inhibitors during the preclinical phase]. Anasthesiol Intensivmed Notfallmed Schmerzther 1992, 27:31-36. 10.1055/s-2007-1000248, 1387007.
36. Plotkin AJ, Wade CE, Jenkins DH, Smith KA, Noe JC, Park MS, Perkins JG, Holcomb JB. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008, 64:S64-68. 10.1097/TA.0b013e318160772d, 18376174.
37. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009, 102:793-799. 10.1093/bja/aep098, 19420005.
38. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003, 89:9-12.
39. Sniecinski RM, Chen EP, Tanaka KA. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis 2008, 19:178-179. 10.1097/MBC.0b013e3282f40d4a, 18277140.
40. Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009, 19710609, 10.1097/MBC.0b013e32832da1c5.
41. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009, 108:751-758. 10.1213/ane.0b013e3181966675, 19224779.
42. Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Klingler A, Klima G, Martinowitz U, Fries D. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007, 5:1019-1025. 10.1111/j.1538-7836.2007.02481.x, 17461931.
43. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009, 7:1099-1105. 10.1111/j.1538-7836.2009.03460.x, 19422451.
44. Schöchl H. Coagulation management in major trauma. Hamostaseologie 2006, 26:S52-55.
45. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004, 125:69-73. 10.1111/j.1365-2141.2004.04868.x, 15015971.
46. Dara SI, Rana R, Afessa B, Moore SB, Gajic O. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005, 33:2667-2671. 10.1097/01.CCM.0000186745.53059.F0, 16276195.
47. Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg 2007, 109:166-171. 10.1016/j.clineuro.2006.09.001, 17029771.
48. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, Hubmayr RD, Gajic O. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007, 131:1308-1314. 10.1378/chest.06-3048, 17400669.
49. Snyder CW, Weinberg JA, McGwin G, Melton SM, George RL, Reiff DA, Cross JM, Hubbard-Brown J, Rue LW, Kerby JD. The relationship of blood product ratio to mortality: survival benefit or survival bias?. J Trauma 2009, 66:358-362. 10.1097/TA.0b013e318196c3ac, 19204508.
50. Geeraedts LM, Demiral H, Schaap NP, Kamphuisen PW, Pompe JC, Frolke JP. 'Blind' transfusion of blood products in exsanguinating trauma patients. Resuscitation 2007, 73:382-388. 10.1016/j.resuscitation.2006.10.005, 17292528.
51. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004, 3:324-330.
52. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT?. J Thromb Haemost 2005, 3:2607-2611. 10.1111/j.1538-7836.2005.01552.x, 16150051.
53. Dempfle CE, Borggrefe M. Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 2008, 34:445-450. 10.1055/s-0028-1092874, 18956284.
54. Jackson GN, Ashpole KJ, Yentis SM. The TEG vs the ROTEM thromboelastography/thromboelastometry systems. Anaesthesia 2009, 64:212-215. 10.1111/j.1365-2044.2008.05752.x, 19143701.
55. Kheirabadi BS, Crissey JM, Deguzman R, Holcomb JB. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 2007, 62:1352-1359. 10.1097/TA.0b013e318047b805, 17563647.
56. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008, 65:535-543. 10.1097/TA.0b013e31818379a6, 18784565.
57. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009, 7:795-802. 10.1111/j.1538-7836.2009.03331.x, 19320829.
58. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009, 22:267-274. 10.1097/ACO.0b013e32832678d9, 19390253.
59. Gerlach R, Krause M, Seifert V, Goerlinger K. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien) 2009, 151:873-900. 10.1007/s00701-009-0409-z, 19557305.
60. Kashuk JL, Moore EE, Le T, Lawrence J, Pezold M, Johnson JL, Cothren CC, Biffl WL, Barnett C, Sabel A. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography. J Surg Res 2009, 156:133-138. 10.1016/j.jss.2009.03.046, 19577246.
61. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice?. Curr Opin Anaesthesiol 2009, 22:305-312. 10.1097/ACO.0b013e3283212c7c, 19390257.
62. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009, 138:694-702. 10.1016/j.jtcvs.2008.11.065, 19698858.
63. Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 2009, 7:2064-2069. 10.1111/j.1538-7836.2009.03633.x, 19804533.
64. Craig J, Aguiar-Ibanez R, Bhattacharya S, Downie S, Duff S, Kohli H, Nimmo A, Trueman P, Wilson S, Yunni Y. The clinical and cost effectiveness of thromboelastography/thromboelastometry. Health Technol Assess 2008, 11:1-70.
65. Moore L, Lavoie A, Turgeon AF, Abdous B, Le Sage N, Emond M, Liberman M, Bergeron E. The trauma risk adjustment model: a new model for evaluating trauma care. Ann Surg 2009, 249:1040-1046. 10.1097/SLA.0b013e3181a6cd97, 19474674.
66. Hirschmann MT, Uike KN, Kaufmann M, Huegli R, Regazzoni P, Gross T. Quality management of interdisciplinary treatment of polytrauma. Possibilities and limits of retrospective routine data collection. Anaesthesist 2007, 56:673-678. 10.1007/s00101-007-1192-y, 17483913.
67. Sanson G, Di Bartolomeo S, Nardi G, Albanese P, Diani A, Raffin L, Filippetto C, Cattarossi A, Scian E, Rizzi L. Road traffic accidents with vehicular entrapment: incidence of major injuries and need for advanced life support. Eur J Emerg Med 1999, 6:285-291.